Creekmur Asset Management’s ARK Genomic Revolution ETF ARKG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
– Sell
-1
Closed -$23 – 1022
2024
Q2
$23 Hold
1
– – ﹤0.01% 1012
2024
Q1
$29 Hold
1
– – ﹤0.01% 818
2023
Q4
$33 Buy
+1
New +$27 ﹤0.01% 780

Other funds holding ARKG

Creekmur Asset Management's ARKG Position: Q3 2024 in Review

Creekmur Asset Management sold out of ARK Genomic Revolution ETF (ARKG) in Q3 2024, closing a stake of 1 share — an estimated $23 sold.

Creekmur Asset Management first reported a position in ARKG in Q4 2023 and held it in 3 quarters. The position peaked at $33 in Q4 2023. 240 funds tracked by Wall St. Rank hold ARKG as of Q3 2024.

  • Creekmur Asset Management reported no remaining ARK Genomic Revolution ETF position as of Q3 2024 after selling out during the quarter.
  • Creekmur Asset Management sold 1 ARK Genomic Revolution ETF share in Q3 2024, an estimated $23.
  • Creekmur Asset Management first reported a position in ARK Genomic Revolution ETF in Q4 2023 and held it in 3 quarters.
  • Creekmur Asset Management's ARK Genomic Revolution ETF position peaked at $33 in Q4 2023.
  • 240 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q3 2024.

Based on Creekmur Asset Management's 13F filing for Q3 2024, filed 25 Oct 2024.